These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24680008)

  • 21. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R;
    Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to Birbeck et al.
    Wright E; Brew BJ; Lal L; Ali ST; Arayawichanont A; Imran D; Kamarulzaman A; Kongsaengdao S; Kruy L; Merati TP; Samintharapanya K; Sarim C; Tau G; Thangsing C; Vin-Samnang C; Wesselingh SL
    Epilepsia; 2008 Mar; 49(3):541-3. PubMed ID: 18302631
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV and malaria interactions: where do we stand?
    González R; Ataíde R; Naniche D; Menéndez C; Mayor A
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):153-65. PubMed ID: 22339190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy.
    Peterson K; van Griensven J; Huis in 't Veld D; Colebunders R
    Expert Rev Anti Infect Ther; 2012 Jan; 10(1):43-50. PubMed ID: 22149613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The obstetric face and challenge of HIV/AIDS.
    Guidozzi F; Black V
    Clin Obstet Gynecol; 2009 Jun; 52(2):270-84. PubMed ID: 19407534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment. Individual approach needed for co-infections.
    AIDS Policy Law; 2011 Dec; 27(1):1. PubMed ID: 22319816
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Yeager J; Ledsky R; Ng TH; Wagner KF
    Clin Exp Dermatol; 1997 May; 22(3):118-23. PubMed ID: 9425690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Care for HIV/AIDS during parturition].
    Veser T
    Krankenpfl Soins Infirm; 2009; 102(9):24-5. PubMed ID: 19771823
    [No Abstract]   [Full Text] [Related]  

  • 29. Kaposi's sarcoma in sub-Saharan Africa: a current perspective.
    Mosam A; Aboobaker J; Shaik F
    Curr Opin Infect Dis; 2010 Apr; 23(2):119-23. PubMed ID: 19996745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV/AIDS in 2004: the epidemiologist's point of view.
    Girardi E; Lauria FN; Ippolito G
    Cell Death Differ; 2005 Aug; 12 Suppl 1():837-44. PubMed ID: 15776000
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity.
    Martin AM; Nolan D; Gaudieri S; Phillips E; Mallal S
    Pharmacogenomics; 2004 Sep; 5(6):643-55. PubMed ID: 15335286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High rates of regimen change due to drug toxicity among a cohort of South Indian adults with HIV infection initiated on generic, first-line antiretroviral treatment.
    Sivadasan A; Abraham OC; Rupali P; Pulimood SA; Rajan J; Rajkumar S; Zachariah A; Kannangai R; Kandathil AJ; Sridharan G; Mathai D
    J Assoc Physicians India; 2009 May; 57():384-8. PubMed ID: 19634284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.
    Sutcliffe CG; van Dijk JH; Bolton C; Persaud D; Moss WJ
    Lancet Infect Dis; 2008 Aug; 8(8):477-89. PubMed ID: 18652994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV immune reconstitution syndrome in sub-Saharan Africa.
    Murdoch DM; Venter WD; Feldman C; Van Rie A
    AIDS; 2008 Aug; 22(13):1689-90. PubMed ID: 18670236
    [No Abstract]   [Full Text] [Related]  

  • 36. Stevens-Johnson syndrome in an HIV-infected patient.
    Blitz M; Spivack E; Kerpel SM; Freedman PD
    AIDS Read; 1999; 9(3):184-5, 190. PubMed ID: 12728904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-exposure chemoprophylaxis for HIV: it is time.
    Smith SM
    Retrovirology; 2004 Jul; 1():16. PubMed ID: 15238164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remodeling pharmaceutical care in Sub-Saharan Africa (SSA) amidst human resources challenges and the HIV/AIDS pandemic.
    King RC; Fomundam HN
    Int J Health Plann Manage; 2010; 25(1):30-48. PubMed ID: 19387996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timing of antiretroviral drugs during tuberculosis therapy.
    Garcia-Vidal C; Salvado M; Salavert M
    N Engl J Med; 2010 Jun; 362(22):2137-8; author reply 2138-9. PubMed ID: 20527080
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV-infected women in ART programmes.
    Myer L; Morroni C; Nachega J; Cooper D
    Lancet; 2005 Feb 19-25; 365(9460):655-6. PubMed ID: 15721468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.